List of vaccines and treatments for COVID-19
All applications for vaccines and treatments for COVID-19 received by Health Canada.
| Product name | Company name | Product type | Status | Date of approval | Approved for different indication | ID |
|---|---|---|---|---|---|---|
| Casirivimab and imdevimab (casirivimab / imdevimab) | Hoffmann-La Roche Limited | Treatment | Authorized By Interim Order | No | 34 | |
| Janssen COVID-19 Vaccine (Ad26.COV2.S [recombinant]) | Janssen Inc | Vaccine | Authorized By Interim Order | No | 27 | |
| AstraZeneca COVID-19 Vaccine (ChAdOx1-S [recombinant]) | AstraZeneca Canada Inc | Vaccine | Authorized By Interim Order | No | 28 | |
| COVISHIELD (ChAdOx1-S [recombinant]) | Verity Pharmaceuticals Inc/Serum Institute of India (in partnership with AstraZeneca Canada Inc) | Vaccine | Authorized By Interim Order | No | 29 | |
| COVID-19 Vaccine Moderna (mRNA-1273 SARS-CoV-2) | ModernaTX, Inc. | Vaccine | Authorized By Interim Order | No | 15 | |
| Pfizer-BioNTech COVID-19 Vaccine (tozinameran) | BioNTech Manufacturing GmbH | Vaccine | Authorized By Interim Order | No | 16 | |
| Bamlanivimab (bamlanivimab) | Eli Lilly Canada Inc | Treatment | Authorized By Interim Order | No | 8 | |
| Veklury (remdesivir) | Gilead Sciences Canada Inc | Treatment | Authorized | No | 9 | |
| Nitric oxide (nitric oxide) | Sanotize Research & Development Corp. | Treatment | Under review | Under review | Yes | 76 |
| COVID-19 Vaccine Moderna – Application for Pediatric Use (ages 12-17) (mRNA-1273 SARS-CoV-2) | ModernaTX, Inc. | Vaccine | Under review | Under review | No | 55 |
| Regdanvimab (regdanvimab) | Celltrion HealthCare Co Ltd | Treatment | Under review | Under review | No | 53 |
| Olumiant (baricitinib) | Eli Lilly Canada Inc | Treatment | Under review | Under review | Yes | 39 |
| Coronavirus-like Particle (CoVLP) COVID-19 Vaccine (coronavirus-like particle [CoVLP]) | Medicago Inc | Vaccine | Under review | Under review | No | 38 |
| Sotrovimab (sotrovimab) | GlaxoSmithKline Inc | Treatment | Under review | Under review | No | 36 |
| Leronlimab (leronlimab) | CytoDyn, Inc. | Treatment | Under review | Under review | No | 35 |
| Bamlanivimab and etesevimab (LY-CoV555 / LY-CoV016) | Eli Lilly Canada Inc | Treatment | Under review | Under review | No | 32 |
| Novavax COVID-19 Vaccine (NVX-CoV2373) | Novavax Inc | Vaccine | Under review | Under review | No | 31 |
| Favipiravir (favipiravir) | Dr Reddys Laboratories Ltd | Treatment | Under review | Under review | 17 |